SEL 110

N/A

Report date: 2026/03/04 20:01:44

Base Information

Drug NameSEL 110
Drug Alias NameSVP-RSVP RapamycinSEL-110
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Molecular Glue
Mechanisms of ActionMethylmalonyl-CoA Mutase stimulantsSerine/threonine-protein kinase mTOR inhibitors
TargetsMethylmalonyl-CoA MutaseSerine/threonine-protein kinase mTOR
Therapy Area/IndicationsGout
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSelecta Biosciences IncWelichem Biotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSelecta Biosciences Inc
Active IndicationsN/A
Inactive IndicationsGout

Other Information

ATC CodeN/A
Related LinksN/A